My NCBI | Sign In
RSS Settings
  • Search: Pérez-Elías Maria[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 42

    1.

    Short-term effect of ritonavir-boosted atazanavir in hepatitis B and/or C co-infected, treatment-experienced HIV patients.

    Pérez-Elías MJ, Gatell JM, Flores J, Santos J, Vera-Médez F, Clotet B, Moreno A, Pérez-Molina JA, Vendrell B, Serrano O.

    HIV Clin Trials. 2009 Jul-Aug;10(4):269-75.PMID: 19723614 [PubMed - indexed for MEDLINE]Related articles

    2.

    Observational study to evaluate clinical outcomes after first-line efavirenz-or lopinavir-ritonavir-based HAART in treatment-naive patients.

    Pérez-Elías MJ, Moreno A, Casado JL, Dronda F, Antela A, López D, Quereda C, Navas E, Hermida JM, Del Sol E, Moreno S.

    J Int Assoc Physicians AIDS Care (Chic Ill). 2009 Sep-Oct;8(5):308-13. Epub 2009 Aug 31.PMID: 19721095 [PubMed - in process]Related articles

    3.

    Clinicoepidemiological characteristics of HIV-infected immigrants attended at a tropical medicine referral unit.

    Pérez-Molina JA, López-Vélez R, Navarro M, Pérez-Elías MJ, Moreno S.

    J Travel Med. 2009 Jul-Aug;16(4):248-52.PMID: 19674264 [PubMed - in process]Related articles

    4.

    Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment.

    Pérez-Elías MJ, Morellon ML, Ortega E, Hernández-Quero J, Rodríguez-Torres M, Clotet B, Felizarta F, Gutiérrez F, Pineda JA, Nichols G, Lou Y, Wire MB.

    Antimicrob Agents Chemother. 2009 Dec;53(12):5185-96. Epub 2009 Aug 10.PMID: 19667283 [PubMed - in process]Related articles

    5.

    A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.

    Wang D, Larder B, Revell A, Montaner J, Harrigan R, De Wolf F, Lange J, Wegner S, Ruiz L, Pérez-Elías MJ, Emery S, Gatell J, D'Arminio Monforte A, Torti C, Zazzi M, Lane C.

    Artif Intell Med. 2009 Sep;47(1):63-74. Epub 2009 Jun 12.PMID: 19524413 [PubMed - indexed for MEDLINE]Related articles

    6.

    HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations.

    Garriga C, Pérez-Elías MJ, Delgado R, Ruiz L, Pérez-Alvarez L, Pumarola T, López-Lirola A, González-García J, Menéndez-Arias L; Spanish Group for the Study of Antiretroviral Drug Resistance.

    J Antimicrob Chemother. 2009 Aug;64(2):251-8. Epub 2009 Jun 7.PMID: 19505892 [PubMed - indexed for MEDLINE]Related articles

    7.

    Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression.

    Pulido F, Pérez-Valero I, Delgado R, Arranz A, Pasquau J, Portilla J, Rubio R, González-García J, Miralles P, Pérez-Elías MJ, Ocampo A, Hernando A, Estrada V, Clotet B, Podzamczer D, Arribas JR.

    Antivir Ther. 2009;14(2):195-201.PMID: 19430094 [PubMed - indexed for MEDLINE]Related articles

    8.

    Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis.

    Arribas JR, Delgado R, Arranz A, Muñoz R, Portilla J, Pasquau J, Pérez-Elias MJ, Iribarren JA, Rubio R, Ocampo A, Sánchez-Conde M, Knobel H, Arazo P, Sanz J, López-Aldeguer J, Montes ML, Pulido F; OK04 Study Group.

    J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):147-52.PMID: 19349870 [PubMed - indexed for MEDLINE]Related articles

    9.

    Tuberculosis complicating hepatitis C treatment in HIV-infected patients.

    Pérez-Elías MJ, García-San Miguel L, González García J, Montes Ramírez ML, Muriel A, Machín-Lázaro JM, Martínez-Baltanás A, Zamora F, Moreno A, Martín-Dávila P, Quereda C, Gómez-Mampaso E, Moreno S.

    Clin Infect Dis. 2009 Apr 15;48(8):e82-5.PMID: 19275500 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effect of treatment with efavirenz on neuropsychiatric adverse events of interferon in HIV/HCV-coinfected patients.

    Quereda C, Corral I, Moreno A, Pérez-Elías MJ, Casado JL, Dronda F, Rodríguez-Sagrado MA, Hernández B, Moreno S.

    J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):61-3.PMID: 18667933 [PubMed - indexed for MEDLINE]Related articles

    11.

    Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation.

    Moreno A, Bárcena R, Quereda C, Casado JL, Pérez-Elías MJ, Fortún J, Nuño J, Arranz I, Moreno S.

    AIDS. 2008 Feb 19;22(4):547-8. No abstract available. PMID: 18301075 [PubMed - indexed for MEDLINE]Related articles

    12.

    Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.

    Pulido F, Arribas JR, Delgado R, Cabrero E, González-García J, Pérez-Elias MJ, Arranz A, Portilla J, Pasquau J, Iribarren JA, Rubio R, Norton M; OK04 Study Group.

    AIDS. 2008 Jan 11;22(2):F1-9.PMID: 18097218 [PubMed - indexed for MEDLINE]Related articles

    13.

    Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments.

    Garriga C, Pérez-Elías MJ, Delgado R, Ruiz L, Nájera R, Pumarola T, Alonso-Socas Mdel M, García-Bujalance S, Menéndez-Arias L; Spanish Group for the Study of Antiretroviral Drug Resistance.

    J Med Virol. 2007 Nov;79(11):1617-28.PMID: 17854027 [PubMed - indexed for MEDLINE]Related articles

    14.

    The development of artificial neural networks to predict virological response to combination HIV therapy.

    Larder B, Wang D, Revell A, Montaner J, Harrigan R, De Wolf F, Lange J, Wegner S, Ruiz L, Pérez-Elías MJ, Emery S, Gatell J, Monforte AD, Torti C, Zazzi M, Lane C.

    Antivir Ther. 2007;12(1):15-24.PMID: 17503743 [PubMed - indexed for MEDLINE]Related articles

    15.

    Atazanavir: simplicity and convenience in different scenarios.

    Pérez-Elías MJ.

    Expert Opin Pharmacother. 2007 Apr;8(5):689-700. Review.PMID: 17376023 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Cost of nucleoside analogue reverse transcriptase inhibitor-related toxicity in HIV-1-infected patients]

    Llibre-Codina JM, Casado-Gómez MA, Sánchez-de la Rosa R, Pérez-Elías MJ, Santos-González J, Miralles-Alvarez C, Martínez-Chamorro E, Domingo-Pedrol P, Alvarez-García ML, Moreno-Guillén S.

    Enferm Infecc Microbiol Clin. 2007 Feb;25(2):98-107. Spanish. PMID: 17288907 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Severity of the toxicity associated with combinations that include didanosine plus stavudine in HIV-infected experienced patients.

    Hernández B, Moreno S, Pérez-Elías MJ, Casado JL, Dronda F, Moreno A, Antela A.

    J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):556-9.PMID: 17057611 [PubMed - indexed for MEDLINE]Related articles

    18.

    Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature.

    Moreno A, Moreno A, Pérez-Elías MJ, Quereda C, Fernández-Muñoz R, Antela A, Moreno L, Bárcena R, López-San Román A, Celma ML, García-Martos M, Moreno S.

    Hum Pathol. 2006 Oct;37(10):1344-9. Epub 2006 Jul 27.PMID: 16949926 [PubMed - indexed for MEDLINE]Related articles

    19.

    Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir.

    Llibre JM, Domingo P, Palacios R, Santos J, Pérez-Elías MJ, Sánchez-de la Rosa R, Miralles C, Antela A, Moreno S; Lipo-Rec Study Group.

    AIDS. 2006 Jun 26;20(10):1407-14.PMID: 16791015 [PubMed - indexed for MEDLINE]Related articles

    20.

    A dual superinfection and recombination within HIV-1 subtype B 12 years after primoinfection.

    Pernas M, Casado C, Fuentes R, Pérez-Elías MJ, López-Galíndez C.

    J Acquir Immune Defic Syndr. 2006 May;42(1):12-8.PMID: 16763489 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity